Short-term revision rate of Rigicon Testi10 TM testicular prosthesis in adolescents and adults: a retrospective chart review.
Autor: | Atwater BL; Section of Urology, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA., Kirkik D; Rigicon Scientific Editor, Istanbul, Turkey., Wilson SK; Institute for Urologic Excellence, La Quinta, CA, USA., Koca O; Department of Urology, Medistate Kavacik Hospital, Istanbul, Turkey., Purohit RS; Department of Urology, Mount Sinai Hospital, New York, NY, USA., Muñoz Vera C; Department of Urology, Hospital Edgardo Rebagliati Martins, Lima, Peru., Dunglison N; Wesley Urology Clinic, Brisbane, QLD, Australia., Gross MS; Section of Urology, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. Martin.S.Gross@hitchcock.org. |
---|---|
Jazyk: | angličtina |
Zdroj: | International journal of impotence research [Int J Impot Res] 2024 May 07. Date of Electronic Publication: 2024 May 07. |
DOI: | 10.1038/s41443-024-00893-8 |
Abstrakt: | Testicular prosthesis implantation is a valuable solution for the physical, cosmetic, and psychological challenges associated with testicular loss which may affect males of any age. We evaluated the safety and reliability of the new Rigicon Testi10 TM testicular prosthesis in adults and adolescents by performing an IRB-approved retrospective study of data drawn from Patient Information Forms (PIFs). A total of 427 patients (382 adults and 45 adolescents) had at least one testicular prosthesis implanted. Only one adult patient required revision surgery due to rupture of the Rigicon Testi10 TM saline-filled prosthesis. A 40-year-old patient was found to have a leaking prosthesis approximately one week postoperatively, which was suspected to be due to inadvertently punctured by the surgeon during the sterile saline filling process. There were no post-implantation revisions required for adolescent patients. According to our results, Kaplan-Meier calculation of survival from removal or revision was 99.8% for all patients at 54 months (99.7% for adults and 100% for adolescents). The complication rates among patients in this study are lower than those reported in previous published studies. Our study underscores the generally safe nature of testicular prosthesis implantation, as well as the very rare incidence of revision surgery for this new device. (© 2024. The Author(s), under exclusive licence to Springer Nature Limited.) |
Databáze: | MEDLINE |
Externí odkaz: |